Case Study

The Case For Patient Diversity In Clinical Trials


Two of America’s greatest assets are its diverse demographics and its relentless pursuit of new medicines and treatments to improve patient lives worldwide. Unfortunately, it’s a widely known (but little discussed) challenge that the two do not go hand in hand. Minority participation in clinical trials is staggeringly deficient.

For example, America contains over 39 million African-Americans and 52 million Hispanic Americans. While these groups represent 28% of the nation, they only account for 6% of clinical trial patients.

It’s critical that the industry solves this challenge soon, as it is only going to intensify over time. By 2050, minorities will account for more than half of the American population with Hispanic populations representing more than 29% of the nation.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader